The aim of this study was to develop a risk score to predict the 4-year risk of diabetes in a middleaged Korean cohort.
ype 2 diabetes mellitus is a common chronic disease that leads to death and numerous serious complications constituting a large burden on patients, their families, and the health-care system. Diabetic patients have higher occurrences of cardiovascular events and cardiovascular-induced complications than non-diabetic patients. 1,2 Prevalence rates of diabetes in developing countries are already high and expected to rise more quickly than that in developed countries. 3 In Korea, the prevalence of diabetes has increased 6-to 7-fold from 1.5% to 9.9% over the past 40 years. 4 The prevention of diabetes and its associated burden has thus become a major health priority worldwide. 5 Several clinical trials have demonstrated the prevention of type 2 diabetes by lifestyle modifications in high-risk individuals with impaired glucose tolerance. 6, 7 Predicting the risk of diabetes is therefore a requirement for the targeted prevention of the disease.
In this regard, numerous diabetes risk score models have been developed. Some have been derived from cross-sectional studies and thus identify individuals that are currently diabetic. 8- 11 Several investigators have developed risk scores that predict new incidences of diabetes based on cohort data from the Finnish Cardiovascular Risk Factor (FINRISK) study, 12 the European Prospective Investigation into Cancer and Nutrition (EPIC)-Potsdam study, 13 and the Atherosclerosis Risk in Communities (ARIC) study. 14 However, such studies in the Asian population are rare. 15 Among those studies with a cohort design, the majority were developed in Caucasians 12-14, 16 and contain variables that might not be readily applicable to other populations.
The purpose of this study was to develop a simple risk score for predicting the incidence of diabetes in a middle-aged Korean Risk Score for Type 2 Diabetes in Korea cohort.
Methods

Subjects
The Korean Genome and Epidemiology Study (KoGES) is an ongoing community-based prospective cohort study that began in 2001 with the support of the Korean National Institute of Health. In the baseline examination, 10,038 participants agreed to participate in the study. A baseline examination was performed in [2001] [2002] [2003] , and follow-up examinations have been conducted approximately every 2 years. Participants included residents from an industrialized area (Ansan) and a rural area (Ansung). The study has been described in detail previously. 17 The baseline, and initial 2-year (2003-2005, n=8 ,603) and 4-year (2005-2007 , n=7,515) follow-up data are open to researchers for public use, and we obtained the data from all participants for analyses from the Center for Genome Science in the National Institute of Health, Korea. Of 10,038 participants, we excluded those who did not attend follow-up examinations (n=2,330), had died during the follow-up period (n=193), or who had prevalent diabetes or newly diagnosed diabetes (n=1,034) and incomplete data (n=110) in the baseline examination. Finally, 6,342 participants between the ages of 40 and 69 years were selected for analysis. The study protocol was approved by the Institutional Review Board of the Korea Centers for Disease Control and Prevention (KCDC).
Measurements and Surveys
Anthropometric measurements were taken from each participant, blood was drawn for blood chemistry tests, and a questionnaire was administered. Height and body weight were measured to the nearest 0.1 cm and 0.2 kg, respectively, and the body mass index (BMI) was calculated as the weight in kilograms divided by the height in meters squared. Blood pressure was measured using the left and right arm of seated participants by trained technicians using mercury sphygmomanometers (Baumanometer-Standby; W.A. Baum Co, Inc, New York, NY, USA), a cuff of the appropriate size, and a standard protocol. Participants had rested in a chair for 5 min before their blood pressure was measured, and the average of 2 readings was considered as the measure of systolic and diastolic blood pressure. Hypertension was defined as systolic blood pressure ≥140 mmHg or diastolic blood pressure ≥90 mmHg, or after the reported use of antihypertensive medications. Blood samples were obtained after an overnight fast of at least 8 h, and biochemical assays including plasma glucose, insulin, total cholesterol, triglycerides (TG), and high-density lipoprotein cholesterol (HDL-C) were performed by a central laboratory (Seoul Clinical Laboratories, Seoul, Republic of Korea). Blood glucose and insulin levels were measured after fasting, and at 1 and 2 h after the ingestion of a standard 75-g glucose load.
Diabetes was diagnosed according to the American Diabetes Association criteria 18 as a fasting plasma glucose (FPG) level of ≥126 mg/dl or 2-h post-challenge plasma glucose (2 h-PCPG) ≥200 mg/dl, glycated hemoglobin (HbA1c) ≥6.5% (or ≥48 mmol/mol), or the current use of insulin therapy or antidiabetic medication. The questionnaire included demographic information, lifestyle, personal and familial medical history, smoking status, and alcohol consumption. The participants were classified as non-, ex-, and current drinkers and never-, ex-, and current smokers based on their responses to the questionnaire.
Statistical Analyses
We used multiple logistic regression analysis to establish the model for predicting the risk of diabetes. Significant risk factors for predicting diabetes were identified by entering the risk predictors such as age, sex, BMI, parental or sibling history of diabetes, smoking status, FPG, HDL-C, TG, HbA1c, waist circumference (WC), and hypertension status. Interaction terms between the independent variables were not considered in order to establish a diabetes risk score that could be easily used. Smoking history was divided into 2 categories as never or ever smoker (reference) and current smoker.
Continuous , and 5.5-6.4 %). We decided on 5.5% as the cut-off point of HbA1c, which yields a sensitivity of at least 80% and maximum specificity simultaneously. In the case of HDL-C, both male and female participants had the same cut-off point; 50 (mg/dl) that yielded at least 80% sensitivity for predicting the risk.
We developed 3 different models to estimate the risk of diabetes. The basic model was based only on the parameters that were easy to assess without biochemical testing. The risk factors for the incidence of diabetes in the basic model were: age, parental or sibling history of diabetes, smoking status, BMI and hypertension status. Clinical model 1 was created by adding biochemical risk factors including FPG, HDL-C status, and TG to the basic model. Clinical model 2 included the addition of HbA1c to clinical model 1.
For each logistic model, the accuracy of the model was assessed by examining both discrimination and calibration. Discrimination is the ability of a prediction model to separate those who experience a diabetic event from those who do not. We quantified this by calculating c-statistics, which are analogous to the area under a receiver operating characteristic curve (AROC). This value represents an estimate of the probability that a model assigns a higher risk to those who develop diabetes within a 4-year follow up than to those who do not. For each model, the AROC was calculated. Calibration is a measure of the agreement between the predicted probabilities and the actual observed risk. For this we used the Hosmer-Lemeshow χ2 statistics. Moreover, net reclassification improvement (NRI) and integrated discrimination improvement (IDI) were used to examine whether prediction on the basis of the clinical model was significantly improved after adding HbA1c. 19, 20 The regression coefficients of the models were used to assign a point value for each variable, and the diabetes risk score was calculated as the sum of those points. This diabetes risk score was related to the actual incidence rate. The general method for producing a point-score system has been described by Sullivan et al. 21 Internal validity for the final model was conducted using a 10-fold cross-validation technique. 22 The original data set was randomly partitioned into 10 equally sized subsamples. Of the 10 subsamples, a single sample acted as a validation data set for testing the prediction model, and the remaining 9 subsamples were treated as training data sets. The cross-validation technique is then repeated 10 times, with each of the 10 subsamples being used exactly once as the validation data. The average for these 10 iterations was calculated for assessing the reliability for the model.
A two-tailed P value <0.05 was considered to indicate statistical significance. Statistical analyses were performed using LIM NK et al.
the SAS software (version 9.1.3.; SAS Institute, Cary, NC, USA).
Results
Of the 6,342 participants without diabetes at baseline in this cohort study, 436 participants developed type 2 diabetes during the 4-year follow up. Table 1 shows the baseline characteristics of the study population. The mean age was 51.6 years, approximately half of the participants were women (52.4%), and the average BMI was 24.5. Participants who developed diabetes had higher BMI, FPG, TG, and HbA1c, a higher prevalence of a parental or sibling history of diabetes, and higher incidence of a current smoking and hypertension status than Table 2 also shows the Hosmer-Lemeshow χ2 statistics evaluating the calibration of the models. None of the models showed a significant difference between the predicted and observed incidence of type 2 diabetes. The results of the basic model indicated that older age, a higher BMI, current smoking status, hypertensive and a parental or sibling history of diabetes significantly increased the risk of developing diabetes during the 4-year follow-up period. Clinical models 1 and 2 in Table 2 included information from blood biochemical testing, including FPG, HDL-C, TG, and HbA1c. In these models, all variables were statistically significant predictors of the risk for development of diabetes, with the exception of current smoking status in the second clinical model. In particular, a higher FPG and HbA1c, which were included in the second clinical model, were associated with significantly high odds ratios (OR) of 3.19 (95% confidence interval (CI), 2.26-4.50) and 2.66 (95% CI, 2.02-3.51), respectively.
The AROC for the basic model and the 2 clinical models were evaluated ( Table 2 To examine whether the prediction using the clinical model with HbA1c was significantly improved, reclassification of the model with the addition of HbA1c was assessed by calculating the NRI and IDI. Table 3 presents the results of the risk reclassification for the prediction models with and without HbA1c. When the NRI and IDI statistics were calculated, 105 (24.1%) of the cases who developed diabetes correctly moved up 1 risk category and 33 (7.6%) of the cases incorrectly moved down, when HbA1c was added to the prediction model. This resulted in a relative improvement of 16.5% among those who developed diabetes. For those who did not develop diabetes, 990 (16.8%) correctly moved down, whereas 769 (13.0%) incorrectly moved up in risk category. Therefore, the NRI was estimated at 12.8%, which was statistically significant (P<0.001). The IDI is the difference in the discrimination slope between the 2 models where the discrimination slope is the mean difference in predicted risk between cases and non-cases. 19 In the model without HbA1c, the average predicted risk was 14.4% for those who developed diabetes (cases) and 6.3% for those who did not (non-cases). In this case, the discrimination slope was 8.1%. In the model including HbA1c, the averages were 15.4% for the cases and 6.2% for the non-cases. In this case, the slope was 9.2%. Therefore, the IDI for HbA1c was calculated at 1.1% (P<0.0001). This means that the difference in average predicted risks between cases and controls increased by 0.011 when HbA1c was added to the model. Both the NRI and IDI statistics suggested that the addition of HbA1c to the prediction model resulted in a significant improvement in the model performance.
A point-score system for the risk of diabetes was therefore constructed to estimate the risk of diabetes based on the second clinical model with HbA1c ( Table 4 ). The total score of the point system ranged between -17 and 83. Through the use of the point-score system, we determined that 54.1% of the samples had a less than 5% risk, 26.8% had a 5% to <10% risk, and 19.1% had a greater than 10% risk of developing diabetes during the 4-year follow up. The AROC calculated by the point score system was 0.76 (95% CI, 0.74-0.79), which is almost identical to that for the second clinical model. To finalize the model, the internal validity was assessed using a 10-fold cross-validation procedure. This technique provides an estimate of the performance of the model when applied to a new patient. Following a 10-fold cross-validation, the estimate of the AROC was 0.76 (95% CI, 0.73-0.78), demonstrating a robustness and high discrimination reliability for the model. 
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Discussion
In the present study, we examined the risk factors for newly developing type 2 diabetes among individuals in a middleaged Korean cohort, and developed a risk-score system based on easily available demographic and clinical variables. The 9 variables included in our prediction model were: age, parental or sibling history of diabetes, BMI, hypertension and smoking status, FPG, HDL-C, TG, and HbA1c. These can all be readily assessed in daily practice, requiring at most a simple blood test and a questionnaire. The risk score we developed displayed good discrimination ability (AROC, 0.77, 95% CI, 0.74-0.79) and calibration (Hosmer-Lemeshow χ2 statistic, 4.90, P=0.7690). Physicians might therefore apply this score to estimate an individual's risk of developing diabetes and thus provide useful guidelines to patients at high risk. Additionally, the risk score is useful for determining the optimal intervention point for diabetes prevention by classifying individuals in the high-or low-risk groups. During the last decade, many studies have developed risk scores to identify those people at high risk for diabetes in particular ethnic groups. 12,16, 23 Although many risk models have been developed for predicting diabetic risk, there are only a few models based on Asian populations. Recently, a risk pre- diction score using cohort data from a Chinese population has been developed. 24 The components for predicting risk for the Chinese population are very similar to those of our study. The majority of such scores are based on the traditional risk factors including anthropometric variables, sex, family history of diabetes, and biochemical tests. 15 In particular, the 2-h oral glucose tolerance test, which identifies impaired glucose tolerance, has played an important role in the prediction of diabetes. Stern et al 16 developed 2 models to predict the incidence of diabetes: a clinical model using age, sex, ethnicity, fasting glucose, systolic blood pressure, HDL-C, BMI, and a family history of diabetes, as well as a full model that also included a 2-h glucose test, diastolic blood pressure, total and LDL-C, and TG. They reported that the use of a simple clinical model was superior to relying exclusively on the 2-h glucose levels when identifying those individuals at high risk of diabetes, as the addition of the 2-h glucose variable to the clinical model showed negligible improvement. Studies performed in a Middle Eastern adult population also showed that a simple model based on systolic blood pressure, a family history of diabetes, waist-to-height ratio, TG/HDL-C, and FPG was superior to relying exclusively on the 2-h oral glucose tolerance test. 25 The Framingham Offspring Study 23 revealed that a simple clinical model including common metabolic variables efficiently identified those individuals at high risk for diabetes. Those researchers concluded that the use of a complex model including additional variables such as a 2-h oral glucose tolerance test, fasting insulin, C-reactive protein, and a homeostasis model assessment insulin resistance was not required. They additionally demonstrated that models including information generally available prior to a clinic visit with a physician demonstrated low discriminatory ability.
In the present study, we also examined whether the addition of HbA1c without the 2-h glucose tolerance test improved the classification capability of the model. The 2-h glucose tolerance test was not included because it is inconvenient to the patient, and its results are not reproducible. 26 HbA1c has been used as a useful indicator of chronic glycemia. 27 Recently, Sato et al suggested that the combined measurement of FPG and HbA1c was effective for predicting diabetes. 28 They found that both FPG and HbA1c are independently associated with the risk of diabetes. A French cohort study reported the use of HbA1c in identifying subjects with impaired fasting glucose. 29 Other studies have shown that in an outpatient population undergoing screening, HbA1c strongly predicts the development of diabetes and that obese patients are more likely to develop diabetes. 30 A study in Hong Kong found that the paired values for FPG and HbA1c, as well as those for FPG and fructosamine, provided optimal sensitivity and a specificity of over 80% for predicting post-glucose-loading hyperglycemia; furthermore, these paired values helped to identify potential diabetic patients. 27 In the present study, AROC analysis was used to assess the discrimination ability of the models. The model with HbA1c did not provide additional capability to discriminate individuals who developed diabetes from those who did not, although the HbA1c in the clinical model was significantly associated with the incidence of diabetes (P<0.0001). This result differed from the results of Sato et al, 28 who showed that a model including both FPG and HbA1c had a greater AROC than those that included FPG alone. The AROC or cstatistic measure is the most popular method of assessing discriminatory ability, and their interpretation is simple and direct. However this model might not be sensitive to meaningful changes in risk and is particularly suited to retrospective casecontrol studies. 31 Recently, various methods of risk stratification have been proposed. We therefore evaluated the risk reclassification with the use of the HbA1c according to the method developed by Pencina et al. 19 We have shown that the NRI was 12.8% (P<0.0001) and that this value indicated statistically significant improvement when HbA1c was added to the clinical model. The IDI also showed significant improvement (1.1%; P<0.0001). We therefore propose that the best model for the prediction of the risk of diabetes in the Korean population needs to include HbA1c.
A strength of this study was the use of a large community sample that included both urban and rural areas. However, there were several limitations. Primarily, our risk scores were only derived and validated in a Korean community-based cohort and thus might only be applicable to clinical or epidemiological settings. Secondly, even though cross-validation was used to minimize over-interpretation of the data, we cannot ensure generality. Finally, we did not consider physical activity and nutrition as risk factors for the incidence of diabetes, as these variables could not be measured with appropriate accuracy. Several studies including both physical activity and nutritional factors have been reported. 13, 32 In conclusion, we found that a model including HbA1c was effective in estimating the risk of diabetes in a middle-aged Korean cohort, and we constructed a point-score system based on that model.
